A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine

NCT06337643 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Vaccine

Interventions

BIOLOGICAL: MVX01
BIOLOGICAL: MVX01 Placebo

Sponsor

Matrivax Research and Development Corporation